proline has been researched along with daunorubicin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muszyńska, A; Pałka, J; Wolczyński, S | 1 |
| Baptiste, N; Chen, X; Friedlander, P; Prives, C | 1 |
| Chen, M; Feng, W; Huang, Z | 1 |
| Lei, HY; Xiao, XB; Zhao, XL | 1 |
| Aalikhani, M; Alikhani, M; Bazi, Z; Oladnabi, M; Shamsabadi, F | 1 |
5 other study(ies) available for proline and daunorubicin
| Article | Year |
|---|---|
The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
Topics: Antibiotics, Antineoplastic; Blotting, Western; Cell Survival; Cells, Cultured; Child; Chlorides; Collagen; Daunorubicin; Dipeptidases; Dose-Response Relationship, Drug; Doxorubicin; Fibroblasts; Humans; Hydrogen-Ion Concentration; Male; Manganese Compounds; Proline; Skin; Thymidine | 2001 |
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Clone Cells; Colchicine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lung Neoplasms; Models, Biological; Proline; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; Structure-Activity Relationship; Tetracycline; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
[In vitro study of the apoptosis effect of DNR on HL-60 cells and its relationship with ROS, CER and NF-kappaB].
Topics: Apoptosis; Caspase 3; Caspases; Ceramides; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunohistochemistry; NF-kappa B; Proline; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Thiocarbamates | 2002 |
[Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro].
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Proliferation; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Leukocytes, Mononuclear; Proline; Thiocarbamates; Tumor Cells, Cultured | 2005 |
In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques.
Topics: Aminoisobutyric Acids; Aminopterin; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Daunorubicin; Digoxin; Drug Repositioning; Gene Expression; Heart Diseases; Humans; Lactams, Macrocyclic; Leucine; Ligands; Methylergonovine; Molecular Docking Simulation; Morpholines; Proline; Quinoxalines; Sulfonamides | 2021 |